Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Debt to Equity (2016 - 2026)

Avanos Medical's Debt to Equity history spans 12 years, with the latest figure at $0.01 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 15.52% to $0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.01, a 15.52% increase, with the full-year FY2025 number at $0.01, up 15.52% from a year prior.
  • Debt to Equity hit $0.01 in Q4 2025 for Avanos Medical, up from $0.01 in the prior quarter.
  • Over the last five years, Debt to Equity for AVNS hit a ceiling of $0.18 in Q4 2022 and a floor of -$0.22 in Q2 2023.
  • Historically, Debt to Equity has averaged -$0.0 across 5 years, with a median of $0.01 in 2023.
  • The widest YoY moves for Debt to Equity: up 102.8% in 2024, down 2734.87% in 2024.
  • Tracing AVNS's Debt to Equity over 5 years: stood at $0.1 in 2021, then soared by 75.99% to $0.18 in 2022, then crashed by 96.14% to $0.01 in 2023, then soared by 63.1% to $0.01 in 2024, then increased by 15.52% to $0.01 in 2025.
  • Business Quant data shows Debt to Equity for AVNS at $0.01 in Q4 2025, $0.01 in Q3 2025, and -$0.01 in Q2 2025.